Aerovance aerovance.com


Aerovance is a biopharmaceutical company focused on the development and commercialization of clinical-stage products for respiratory and allergic diseases. Aerovance's lead programs are in development for the treatment of uncontrolled asthma and uncontrolled eczema. The company is also developing programs for cystic fibrosis and chronic obstructive pulmonary disease. Aerovance was spun off from Bayer Healthcare's biotechnology unit in August 2004.

Aerovance is a biopharmaceutical company focused on the development and commercialization of clinical-stage products for respiratory and allergic diseases. Aerovance's lead programs are in development for the treatment of uncontrolled asthma and unc...Show all

Company (Alive / Active)

Phone: 510-549-5538

Fax: 510-549-5501

2929 Seventh Street
Suite 120
Berkeley, 94710
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Aerovance $150.5M Mar 18, 2011
Threshold Pharmaceuticals $106.4M Aug 18, 2008
Inhibitex $206.3M Aug 12, 2005
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Aerovance Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 10 investors

Competitors

Company Status Description Investors
See all 15 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)